Sublin B.V.

The Netherlands Kloosterstraat 9, 5349 AB, The Netherlands

About the sponsor

Focus on improving outcomes for patients with Type 1 diabetes mellitus, including strategies for glycemic control and integration with insulin pump therapy.

Insulin pump compatibility
Glycemic variability reduction
Autoimmune beta‑cell preservation

Research aims to align advanced delivery methods with established diabetes care protocols.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.